Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men

British Journal of Clinical Pharmacology

Volumn 58, Issue 3, 2004, Pages 243-248

  Sharman, James E ^a,b   Gunaruwan, Prasad ^c   Knez, Wade L ^a   Schmitt, Matthias ^c   Marsh, Susan A ^a   Wilson, Gary R ^a   Cockcroft, John R ^c   Coombes, Jeff S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Australasian Ctr Ageing St Lucia   (Australia)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Free radicals; Haemodynamics; Lipoic acid

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTERY RESISTANCE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL TONE; BRACHIAL ARTERY; CELL LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFENSE MECHANISM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FOREARM BLOOD FLOW; HEMODYNAMICS; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC CIRCULATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; CROSS-OVER STUDIES; FOREARM; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIOCTIC ACID; VASCULAR RESISTANCE;

EID: 4444360210     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02146.x     Document Type: Article

References (31)

1. Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50.
2. Jacob S, Henriksen EJ, Tritschler HJ et al. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 1996; 104: 284-8.
3. Haak E, Usadel KH, Kusterer K et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes 2000; 108: 168-74.
4. Ziegler D, Hanefeld M, Ruhnau KJ et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic add. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38: 1425-33.
5. Nagamatsu M, Nickander KK, Schmelzer JD et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18: 1160-7.
6. Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000; 72: 653S-69S.
7. Suzuki YJ, Tsuchiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 1991; 15: 255-63.
8. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4.
9. Morcos M, Borcea V, Isermann B et al. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 2001; 52: 175-83.
10. Midaoui AE, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension 2002; 39: 303-7.
11. Midaoui AE, Elimadi A, Wu L et al. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens 2003; 16: 173-9.
12. Vasdev S, Ford CA, Parai S et al. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000; 18: 567-73.
13. Heitzer T, Finckh B, Albers S et al. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001; 31: 53-61.
14. Safar ME, Blacher J, Pannier B et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735-8.
15. Teichert J, Kern J, Tritschler HJ et al. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 1998; 36: 625-8.
16. O'Brien E, Mee F, Atkins N et al. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1: 55-61.
17. Chen CH, Nevo E, Fetics B et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95: 1827-36.
18. Murgo JP, Westerhof N, Giolma JP et al. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980; 62: 105-16.
19. Buckberg CD, Fixler DE, Archie JP et al. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 1972; 30: 67-81.
20. Wilkinson IB, Megson IL, MacCallum H et al. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 1999; 34: 690-3.
21. Teichert J, Preiss R. High-performance liquid chromatography methods for determination of lipoic and dihydrolipoic acid in human plasma. Methods Enzymol 1997; 279: 159-66.
22. Sim AS, Salonikas C, Naidoo D et al. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Anal Technol Biomed Life Sci 2003; 785: 337-44.
23. Andersen HR, Nielsen JB, Nielsen F et al. Antioxidative enzyme activities in human erythrocytes. Clin Chem 1997; 43: 562-8.
24. Madesh M, Balasubramanian KA. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys 1998; 35: 184-8.
25. Slaughter MR, O'Brien PJ. Fully-automated spectrophotometric method for measurement of antioxidant activity of catalase. Clin Biochem 2000; 33: 525-34.
26. Benjamin N, Calver A, Collier J et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25: 918-23.
27. McEniery CM, Wilkinson IB, Jenkins DG et al. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension 2002; 40: 202-6.
28. Takaoka M, Kobayashi Y, Yuba M et al. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Pharmacol 2001; 424: 121-9.
29. Packer L. Alpha-lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metab Rev 1998; 30: 245-75.
30. Hermann R, Niebch G, Borbe HO et al. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur J Pharm Sci 1996; 4: 167-74.
31. Breithaupt-Grogler K, Niebch G, Schneider E et al. Dose-proportionality of oral thioctic acid-coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci 1999; 8: 57-65.